Artwork
iconShare
 
Manage episode 478467422 series 2965879
Content provided by Rizwan Chaudhrey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rizwan Chaudhrey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

I sat down with #CAI's VP Marketing and Consulting Services, David Shenberger and Chief Strategy Officer Alice Redmond to look back at 2022, and get some predictions for 2023
We discussed #consolidationofassets and pipelines, #ATMPS, #RegulatoryFrameworks, #AI #Pharma4.0, #ChatGPT, #pharmapricing, #outsourcing and a lot more.
I asked....
2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬
• Can you give me a quick overview of CAI? 00:43
• One word to describe 2022 and why? 01:49
• What were some of CAI key achievements in 2022? 03:00
• Have clients expectations changed since the pandemic? 04:19
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:00
• Does the growth of ATMPS changed how they work with clients? 09:07
• Are there any areas you think the industry could improve? 10:36
2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬
• What are your predictions for the #LifeSciences, #Pharma and #BioPharma in 2023? 12:06
• What developments and trends do you expect to see/predict for #PharmaManufacturing? 16:55
• What can we expect CAI in 2023? 17:44
• Finally, what last thoughts would you like to leave viewers with for 2023? 20:45
🎞 WATCH the interview here https://lnkd.in/eMWuGXmF
Feel free to leave any questions or comments for Alice or David below.
You can learn more about CAI at www.cagents.com

  continue reading

75 episodes